Skip to main content

What is McConnell’s sign


McConnell’s sign is a classic echocardiographic finding described in acute pulmonary embolism (PE), characterized by a distinctive pattern of right ventricular (RV) regional wall motion abnormality.


Definition

McConnell’s sign refers to akinesia or severe hypokinesia of the mid-free wall of the right ventricle with preserved or hyperdynamic apical contraction on transthoracic echocardiography.


Historical Background

First described in 1996 by McConnell et al., the sign was proposed as a specific echocardiographic marker of acute massive pulmonary embolism, helping differentiate acute from chronic RV pressure overload.


Echocardiographic Description

The hallmark components include:


Marked hypokinesia or akinesia of the RV mid-free wall


Normal or hyperdynamic contraction of the RV apex (apical sparing)


Often accompanied by RV dilatation


Reduced tricuspid annular plane systolic excursion (TAPSE)


Elevated pulmonary artery pressures (may be underestimated early)



This peculiar pattern gives the appearance of a “tethered” or paradoxically preserved apex despite global RV dysfunction.


Pathophysiology

The exact mechanism is multifactorial and includes:


Sudden increase in RV afterload due to acute pulmonary arterial obstruction


Ischemia of the RV free wall caused by increased wall stress and reduced coronary perfusion


Mechanical tethering of the RV apex to a normally contracting left ventricle


Geometric distortion of the RV in acute pressure overload



Why the apex is spared remains debated, but ventricular interdependence plays a major role.


Clinical Significance


Suggests acute rather than chronic RV pressure overload


Supports the diagnosis of massive or submassive pulmonary embolism in unstable patients


Useful when CT pulmonary angiography is not immediately available or contraindicated


Associated with worse hemodynamics and higher short-term mortality



Sensitivity and Specificity

Original studies reported high specificity (~94%) but moderate sensitivity. Later data showed that:


Sensitivity is limited


Specificity is lower than initially believed


The sign is supportive but not diagnostic of acute PE



Therefore, McConnell’s sign should always be interpreted in clinical context.


Conditions Other Than Pulmonary Embolism

McConnell’s sign is not exclusive to PE and may be seen in:


Right ventricular myocardial infarction


Acute respiratory distress syndrome (ARDS)


Severe pulmonary hypertension (rarely)


Acute RV strain due to other causes



Hence, false positives can occur.


Differentiation from Chronic Pulmonary Hypertension

Acute PE:


Regional RV dysfunction with apical sparing


Relatively thin RV free wall


Sudden RV dilatation



Chronic pulmonary hypertension:


Global RV hypokinesia


RV hypertrophy


No apical sparing pattern



Associated Echocardiographic Findings in Acute PE


RV/LV ratio > 1


D-shaped left ventricle (septal flattening)


Elevated tricuspid regurgitation velocity


Dilated inferior vena cava with reduced collapse


Reduced RV strain on speckle-tracking echo



Role in Emergency and Critical Care

In hypotensive or shocked patients, bedside echocardiography showing McConnell’s sign can:


Rapidly raise suspicion of massive PE


Prompt immediate anticoagulation or thrombolysis (when appropriate)


Guide urgent decision-making before confirmatory imaging



Limitations


Operator dependent


Not pathognomonic


Can be missed in poor acoustic windows


Should not delay definitive imaging when patient is stable



Key Takeaway

McConnell’s sign is a classic but imperfect echocardiographic marker of acute pulmonary embolism, reflecting acute right ventricular pressure overload with regional wall motion abnormality. It is most valuable as a supportive bedside clue in critically ill patients and must always be integrated with clinical findings, ECG, biomarkers, and definitive imaging.


For more cardiology articles and infographics visit: drmusmanjaved.com



Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...